| Trial ID: | L5335 |
| Source ID: | NCT02832999
|
| Associated Drug: |
Sub Cutaneous Liraglutide
|
| Title: |
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
|
| Acronym: |
LIRAVIS
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: sub cutaneous liraglutide|DRUG: Oral Vildagliptin
|
| Outcome Measures: |
Primary: Insulin sentivity, 2-week change in clamp-measured insulin sensitivity, 2 weeks | Secondary: insulin secretion, 2-week change in meal test measured insulin secretion, 2 weeks|lipid profile, 2-week change in fasting serum lipids, 2 weeks|body weight, 2-week change in body weight, 2 weeks | Other: Renal function, 2-week change in serum creatinine, 2 weeks|Inflammation, 2-week change in C-reactive protein, 2 weeks
|
| Sponsor/Collaborators: |
Sponsor: Yaounde Central Hospital | Collaborators: University of Yaounde 1|University of Buea
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2016-01
|
| Completion Date: |
2016-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-12-26
|
| Locations: |
National Obesity Centre, Yaounde, Cameroon
|
| URL: |
https://clinicaltrials.gov/show/NCT02832999
|
